Patents by Inventor Joel Gelernter

Joel Gelernter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genotype-guided dosing of opioid receptor agonists
    Patent number: 10900082
    Abstract: Provided herein, in some aspects, are methods of dosing opioid receptor agonists for treatment of opioid dependence and pain management.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: January 26, 2021
    Assignees: Yale University, The Trustees of the University of Pennsylvania
    Inventors: Joel Gelernter, Andrew Smith, Henry R. Kranzler
  • GENOTYPE-GUIDED DOSING OF OPIOID RECEPTOR AGONISTS
    Publication number: 20180216188
    Abstract: Provided herein, in some aspects, are methods of dosing opioid receptor agonists for treatment of opioid dependence and pain management.
    Type: Application
    Filed: January 24, 2018
    Publication date: August 2, 2018
    Applicant: Yale University
    Inventors: Joel Gelernter, Andrew Smith, Henry R. Kranzler
  • Treatment response in generalized social phobia
    Patent number: 8026059
    Abstract: This invention generally pertains to the field of psychiatry. In particular, this invention relates to, inter alia, the discovery that a subject's serotonin transporter gene promoter polymorphism genotype can be used to determine the subject's response to certain drug therapies.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: September 27, 2011
    Assignee: The Regents of the University of California
    Inventors: Murray B. Stein, Joel Gelernter
  • Treatment Response in Generalized Social Phobia
    Publication number: 20090220971
    Abstract: This invention generally pertains to the field of psychiatry. In particular, this invention relates to, inter alia, the discovery that a subject's serotonin transporter gene promoter polymorphism genotype can be used to determine the subject's response to certain drug therapies.
    Type: Application
    Filed: February 14, 2007
    Publication date: September 3, 2009
    Inventors: Murray B. Stein, Joel Gelernter
  • Diagnosis of anxiety disorders
    Publication number: 20090209622
    Abstract: The invention relates to methods for diagnosing a genetic predisposition or susceptibility for anxiety disorders in a human. The methods include detecting particular markers at the human RGS2 locus in a sample obtained from the human. The invention also relates to the improved diagnosis that is based on the analysis of haplotypes for the RGS2 locus.
    Type: Application
    Filed: November 21, 2007
    Publication date: August 20, 2009
    Inventors: Jordan W. Smoller, Martin P. Paulus, Joel Gelernter, Murray B. Stein